Helping blood cancer patients in the COVID era
The Oxford-led UK Coronavirus Cancer Monitoring Project was launched earlier this year to help clinicians better treat blood cancer patients in a safe way during the COVID-pandemic
Entries by Oxford Centre
Tackling blood cancers in Tanzania and Uganda
Scientists from Tanzania, Uganda and Oxford University have teamed up in a new child blood cancer program
Previously unknown ‘genetic vulnerability’ in breast cancer found
New Nature paper reveals discovery of a genetic vulnerability in nearly 10% of breast cancer tumours and how this can be targeted to selectively kill cancer cells.
Balancing the benefits and risks of radiotherapy for Hodgkin lymphoma
Dr Rebecca Shakir is devising a tool to allow some blood cancer patients to make more informed decisions about the risks and benefits of their radiotherapy treatment
Epigenetic markers for melanoma patient response to ICB therapy
Development fund winners Rosalin Cooper & Ben Fairfax are investigating the epigenetic landscape of melanoma patients and how it can impact patient sensitivity to ICB therapy
Harnessing immune cell therapy in cancer
Prof Paresh Vyas and his team are investigating how to harness the power of T cells as therapies for patients with a range of blood cancers
New melanoma cancer drug in development shows promise
University of Oxford and Immunocore Ltd have investigated Tebentafusp, a new anti-tumor immune response drug for patients with metastatic melanoma
The relationship between iRhom2 and KRAS proteins
Development Fund winners from the Freeman group are investigating newly discovered proteins and their potential as targets for new cancer treatments
The impact of COVID-19 on cancer patients
A new study from the UK Coronavirus Cancer Monitoring Project (UKCCMP) has investigated which cancer patients may be more susceptible to the impacts of coronavirus
IL-22 pathway linked to poor prognosis in colon cancer
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
